Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cash Flow Statement
Cash Flow Statement
Collplant Biotechnologies Ltd
| Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(11)
|
(11)
|
(11)
|
(7)
|
(6)
|
5
|
1
|
0
|
(4)
|
(15)
|
(16)
|
(17)
|
(17)
|
(7)
|
(7)
|
(7)
|
(7)
|
(17)
|
(17)
|
(17)
|
(14)
|
(13)
|
(12)
|
|
| Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Stock-Based Compensation |
1
|
1
|
1
|
1
|
2
|
1
|
2
|
2
|
2
|
2
|
3
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
5
|
4
|
4
|
3
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
3
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
|
| Change in Working Capital |
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
(0)
|
(1)
|
0
|
(1)
|
(1)
|
(10)
|
(0)
|
1
|
2
|
12
|
1
|
(0)
|
(1)
|
0
|
(0)
|
|
| Cash from Operating Activities |
(6)
N/A
|
(7)
-29%
|
(7)
+0%
|
(4)
+39%
|
(4)
+1%
|
8
N/A
|
3
-56%
|
3
-25%
|
(1)
N/A
|
(12)
-1 648%
|
(13)
-3%
|
(14)
-7%
|
(14)
-2%
|
(14)
+2%
|
(4)
+73%
|
(3)
+27%
|
(3)
+7%
|
(3)
-7%
|
(13)
-371%
|
(14)
-9%
|
(12)
+15%
|
(11)
+12%
|
(10)
+5%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(30)
|
(20)
|
(30)
|
0
|
30
|
20
|
30
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
+42%
|
(1)
+23%
|
(1)
-6%
|
(1)
+25%
|
(31)
-5 808%
|
(21)
+31%
|
(32)
-49%
|
(2)
+95%
|
28
N/A
|
19
-34%
|
29
+54%
|
(1)
N/A
|
(1)
-4%
|
(1)
+6%
|
(1)
-6%
|
(1)
+6%
|
(1)
+12%
|
(1)
+11%
|
(1)
+37%
|
(0)
+14%
|
(0)
+55%
|
(0)
+67%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
5
|
10
|
10
|
4
|
4
|
37
|
39
|
39
|
40
|
3
|
2
|
2
|
1
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
5
N/A
|
10
+84%
|
10
-1%
|
4
-55%
|
4
+0%
|
37
+725%
|
39
+5%
|
39
+0%
|
40
+4%
|
3
-92%
|
2
-52%
|
2
+16%
|
1
-36%
|
1
+8%
|
2
+17%
|
1
-27%
|
0
-71%
|
0
-28%
|
0
-96%
|
0
N/A
|
0
N/A
|
3
N/A
|
3
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Net Change in Cash |
(2)
N/A
|
2
N/A
|
2
+11%
|
(1)
N/A
|
(0)
+38%
|
14
N/A
|
21
+50%
|
10
-53%
|
38
+284%
|
19
-50%
|
7
-63%
|
16
+134%
|
(15)
N/A
|
(14)
+4%
|
(4)
+72%
|
(3)
+17%
|
(4)
-12%
|
(4)
-3%
|
(14)
-277%
|
(15)
-7%
|
(12)
+15%
|
(7)
+40%
|
(7)
+9%
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(7)
N/A
|
(8)
-14%
|
(8)
+3%
|
(5)
+35%
|
(5)
+5%
|
7
N/A
|
2
-70%
|
1
-57%
|
(3)
N/A
|
(14)
-448%
|
(14)
0%
|
(15)
-5%
|
(15)
-1%
|
(15)
+2%
|
(5)
+68%
|
(4)
+23%
|
(3)
+7%
|
(4)
-2%
|
(14)
-288%
|
(15)
-7%
|
(12)
+15%
|
(11)
+14%
|
(10)
+7%
|
|